Variables
Control (n = 26) Training (n = 27)
Demographics
Age, y 59±11 60±9
Gender M / F n (%) 19 (73%) / 7(27%) 20 (74%) / 7 (26%)
BMI, kg/m2 27.4±3.9 27.2±3.9
Hypertension, n (%) 17 (65%) 13 (48%)
Diabetes Mellitus, n (%) 10 (38%) 6 (22%)
Smoker, n (%) 5 (19%) 10 (37%)
Sedentarism, n (%) 26 (100%) 27 (100%)
Previous AMI, n (%) 4 (15%) 3 (11%)
Treatment
Aspirin, n (%) 26 (100%) 27 (100%)
Clopidogrel, n (%) 24 (92%) 27 (100%)
Ticagrelor, n (%) 2 (8%) 0 (0%)
β-blocker, n (%) 17 (65%) 23 (85%)
Event
STEMI, n (%) 14 (54%) 16 (59%)
NSTEMI, n (%) 12 (46%) 11 (41%)
Troponin, ng/mL (median, IQR) 22 (3-50) 32 (11-50)
Risk Scores
TIMI STEMI score 3.3±1.8 2.7±1.8
TIMI NSTEMI score 3.7±1.3 3.2±1.1
GRACE (median, IQR) 129 (120-159) 139 (121-151)
Risk Scores
TIMI STEMI score 3.3±1.8 2.7±1.8
TIMI NSTEMI score 3.7±1.3 3.2±1.1
GRACE (median, IQR) 129 (120-159) 139 (121-151)
Treatment
Fibrinolysis, n (%) 4 (15%) 6 (22%)
Primary PTCA, n (%) 8 (31%) 8 (30%)
Pharmaco-invasive strategy, n (%) 3 (12%) 2 (7%)
BMS, n (%) 19 (73%) 23 (85%)
DES, n (%) 5 (19%) 1 (4%)